Catalyst Wire Dossier Catalyst Wire Dossier

Prandin

repaglinide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Prandin, covering 2006-10-13 to 2018-05-14. Get the full timeline:

Most recent: EMA Authorised: Prandin (repaglinide) — Novo Nordisk A/S

See pricing